Johnson & Johnson

JNJNYSE · USD
271.22USD0.00 (+0.20%)
6710

Johnson & Johnson (JNJ) Expected Move

JNJ expected move through Oct 2, 2026 is 2.4%, with 6 days to expiration. The implied range is $264.64 to $277.80, based on the previous trading day's options prices.

Read more

Tracking the JNJ expected move helps you see how far Johnson & Johnson's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Johnson & Johnson's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the JNJ expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For JNJ, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The JNJ expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Johnson & Johnson is unlikely to go.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand.

Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the JNJ expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Johnson & Johnson expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about JNJ.

JNJ Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Oct 2, 20266$6.582.4%$277.80$264.64
Oct 9, 202613$9.113.4%$280.33$262.11
Oct 16, 202620$14.355.3%$285.57$256.87
Oct 23, 202627$15.905.9%$287.12$255.32

As of September 25, 2026

Know What the Market Expects From JNJ

Track the JNJ expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial